Plakophilin 1 (PKP1) is overexpressed in metastatic melanoma and is a factor of poor prognosis in patients with CM, suggesting a link between PKP1 gene expression and immune efficacy [27]. The gene discussed is PKP1; the disease is cutaneous mastocytosis.